Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone vs Glyburide in Type 2 Diabetes with Mild Cardiac Disease
NCT00521742Phase 3Completed
- Sponsor
- Takeda
- Start
- Mar 2001
- Primary completion
- Jan 2003
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of pioglitazone in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Takeda. Primary endpoint: Change in Walking Distance During a Standardized 6-Minute Walk Test. Started Mar 2001; status: completed.
02
Drugs
pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00521742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00521742.